Metraipolis › archive › dc_b976d4d669ef

Novel strategies for nanovaccine application in breast cancer treatment — Europe PMC PMID:41181604

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41181604
DOI
10.3389/fphar.2025.1691991
License (as archived)
solo-consultazione
Archived
2026-11-09T06:27:41.132Z
SHA-256 of the archived text
ddc37ad2a22595508357bbcbf28dba1419f2b6e07acb1ea402e66726f5f9b577
Stable URL of this page
https://metraipolis.com/documento/dc_b976d4d669ef

How to cite

Novel strategies for nanovaccine application in breast cancer treatment — Europe PMC PMID:41181604 — Europe PMC (en), https://europepmc.org/article/MED/41181604 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b976d4d669ef (Metraipolis archive dc_b976d4d669ef, sha256 ddc37ad2a22595508357bbcbf28dba1419f2b6e07acb1ea402e66726f5f9b577)
BibTeX
@misc{dcb976d4d669ef,
  title = {Novel strategies for nanovaccine application in breast cancer treatment — Europe PMC PMID:41181604},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41181604},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b976d4d669ef; sha256 ddc37ad2a22595508357bbcbf28dba1419f2b6e07acb1ea402e66726f5f9b577},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41181604. Agents can read the archived copy with the MCP tool read_document.